Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Overactive bladder treatment without dry mouth. | Calms an overactive bladder. |
| Body system | Kidney & Bladder | Kidney & Bladder |
| Drug class | Beta-3 agonists | Bladder antimuscarinics |
| Supply | Prescription only | Prescription only |
| Main uses | Overactive bladder | Overactive bladder, Bedwetting in children (second line), Excessive sweating (off-label) |
| How it works | Relaxes the bladder as it fills. | Relaxes the bladder so it holds more. |
| Starts working | — | — |
| Half-life | About 50 hours | 2–5 hours |
| Typical adult dose | 25–50 mg once a day. | 2.5–5 mg two or three times a day, or 5–20 mg modified-release once a day. |
| Forms | Modified-release tablet, Granules (children) | Tablet, Modified-release tablet, Patch, Gel |
| Common side effects | Raised heart rate, Urinary infections, Headache | Dry mouth, Constipation, Blurred vision, Drowsiness |
| Serious side effects | Severely raised blood pressure | Confusion in older people, Urinary retention, Overheating (reduced sweating) |
| Don't take if | — | — |
| Alcohol | — | — |
| Pregnancy | Usually avoidedNot recommended. | Use with cautionLimited data. |
| Breastfeeding | — | — |
| In use since | 2012 | 1975 |
| Brand names | United States: MyrbetriqUnited Kingdom: BetmigaIndia: Mirago, Mirabeg | United States: Ditropan XL, OxytrolUnited Kingdom: Lyrinel XL, KenteraIndia: Oxyspas, Cystran |
| Legal status | — | — |
| ATC code | G04BD12 | G04BD04 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker